Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells

Area of Science:

• Immunology
• Cellular Biology
• Autoimmunity

Background:

• Autoreactive T-cells play a crucial role in autoimmune diseases like type 1 diabetes.
• Understanding T-cell activation requirements is key for developing immunotherapies.

Purpose of the Study:

• To investigate the activation requirements of autoreactive CD4(+) T-cells using MHC class II tetramers.
• To explore the dose-dependent effects of tetramer stimulation on T-cell signaling and function.

Main Methods:

• Derived GAD65-specific HLA-DR0401-restricted T-cell clones from a diabetic patient.
• Utilized major histocompatibility complex (MHC) class II tetramers (TMrs) loaded with an altered GAD peptide (TMr-GAD) for stimulation.
• Assessed early signaling events (PLC-gamma(1) phosphorylation, Ca(2+) mobilization) and later responses (CD69 upregulation, cytokine production, proliferation, apoptosis).

Main Results:

• TMr-GAD efficiently delivered activation signals despite binding limited T-cell receptors.
• Stimulation induced a dose-dependent cascade from early signaling to proliferation.
• High TMr-GAD concentrations led to activation-induced cell death (AICD).
• Lower-avidity T-cell clones showed reduced sensitivity to activation and AICD compared to higher-avidity clones.

Conclusions:

• MHC class II tetramers are potent activators of autoreactive T-cells.
• Activation-induced cell death is a potential therapeutic target for MHC class II multimer applications.
• The resistance of low-avidity T-cells to AICD may pose a challenge for therapeutic efficacy.